Therapeutic Drug Monitoring Market is driven by Rising preference for precision medicine - Says Global Insight Services Analyst

The global therapeutic drug monitoring market was valued at USD 1.4 Billion in 2021 and it is anticipated to grow up to USD 4.5 Billion by 2031, at a CAGR of 12.3% during the forecast period.

To Remain 'Ahead' Of Your Competitors, Request for A Sample: https://www.globalinsightservices.com/request-sample/GIS10369

Therapeutic Drug Monitoring is a medical practice which is used for determining the concentration of particular drug in the bloodstream of the patient at different time interval. It is used in sustaining constant volume drug in the bloodstream without any toxic effect. Therapeutic drug monitoring is not used in majority of drugs but only the drugs which have narrow therapeutic window. It is also used in drugs with marked pharmacokinetic variability.

Market Trends and Drivers:

Rising preference for precision medicine will boost the overall market growth. Precision medicine is an evolving approach for disease treatment and prevention that considers individual variability in genes, environments, and lifestyles. Precision medicine involves selecting drugs wholly tailored to a patient based on disease condition and history. Although this practice is expanding into all disease areas, oncology has seen the most progress.

Read more about Therapeutic Drug Monitoring Market here: https://www.globalinsightservices.com/reports/therapeutic-drug-monitoring-market/

Recently, cancer patients are being provided treatment through combination drugs, based on studies conducted on the patient's parameters such as systems biology, analysis of the tumor, and gene expression data in the absence and presence of pharmacological perturbation. This approach, which is currently being tested in various settings, aims to revolutionize pharmacotherapy in oncology and other disease areas. TDM can be of immense value to advance this novel way of treating patients

COVID-19 Impact:

A worldwide emergency has been caused by the COVID-19 pandemic. Data from the Scottish Biologic Therapeutic Drug Monitoring (TDM) service shows a drop in TDM testing since pandemic onset. For instance, in April 2020, a 75.6% reduction in adalimumab testing and a 36.2% reduction in infliximab testing was noticed, mainly due to a large number of cancellations of outpatient. Likewise, it is also believed that disruption to normal patterns of care and disease monitoring of patients on biologics could increase the threat of disease and adverse clinical reactions.

Get Customized Report as Per Your Requirement: https://www.globalinsightservices.com/request-customization/GIS10369

Research associations and other medical bodies are making various attempts to conduct clinical trials to develop a suitable anti-COVID drug, which is anticipated to fuel the growth of the TDM market. Moreover, the Pharmacology group - AC43 of the National Agency for Research on AIDS and Viral Hepatitis and the Therapeutic Drug Monitoring Group of the French Society of Pharmacology and Therapeutics proposed, at the end of March 2020, that a TDM evaluation be performed 48 hours after the start of treatment to check the early attainment of an adequate residual concentration.

Major Players in the Global Therapeutic Drug Monitoring Market:

The key players in the market are Abbott (US), Thermo Fisher Scientific (US), F. Hoffmann-La Roche Ltd. (Switzerland), Siemens Healthineers AG (Germany), Danaher Corporation (US), Bio-Rad Laboratories (US), bioMérieux SA (France), Theradiag SA (France), Grifols S.A. (Spain), Randox Laboratories Ltd. (Ireland) among others.

For In-Depth Competitive Analysis, Purchase this Report: https://www.globalinsightservices.com/checkout/single_user/GIS10369

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.